STADA AG Successfully Moves to Arvato Systems' Private Cloud
Improved performance by switching from On Premise to SaaS
The Move to the Cloud - All Services from a Single Source
For many years now, the trend has been to move applications to the cloud and use them holistically as Software as a Service, or SaaS for short. Companies buy a scalable and highly available service as a web-based solution. The entire management, including updates and security management, can be taken over by their provider. The data and the application itself are made available in a cloud environment.

Already for the implementation of the EU FMD (Falsified Medicines Directive) requirements in 2016, STADA successfully used the "Arvato CSDB" for the serialization of prescription drugs. In order to be able to work even more efficiently, the application has now moved to the virtual private cloud of Arvato Systems.
Benefits
Moving our Arvato Systems CSDB to the cloud was essential for STADA AG to enable our employees to focus entirely on our core business and growth strategy. Arvato Systems now offers us a one-stop service that supports our growth mindset and, at the same time, allows us to act quickly and flexibly at any time.
About STADA Arzneimittel AG
STADA Arzneimittel AG is headquartered in Bad Vilbel, Hesse. The company relies on a three-pillar strategy consisting of generics, specialty pharmaceuticals, and non-prescription consumer healthcare products. STADA Arzneimittel AG sells its products in around 120 countries worldwide. In 2021, STADA achieved Group sales of €3,249.5 million and earnings before interest, taxes, depreciation, and amortization (EBITDA) of €776.5 million. As of December 31, 2021, STADA employed 12,520 people worldwide.